Literature DB >> 27334456

Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families.

Janice P Dutcher1,2, Peter H Wiernik3,4, Leticia Varella4,5, Rangaswamy Chintapatla4,6.   

Abstract

The relationship between renal cell cancer (RCC) and hematologic malignancy (HM) in the same individual has been reported for more than 20 years, and is noted in SEER database studies. Family histories suggest a familial association as well. This study evaluates the occurrence of renal cell cancer and hematologic malignancies in individual patients and families, and the occurrence of age-of-onset anticipation among generations. Family history data from our familial patient registry, including more than 700 pedigrees of familial hematologic malignancies, and 700 patients with renal cell cancer, were reviewed. Twenty-six patients with a personal history of both RCC and HM are reported. Seventy four patients with RCC are noted to have 95 family members with HM. Consistent with past reports, there was male predominance among the patients with both diseases (71 %), and among the RCC patients' relatives with HM (57 %). Also consistent was a predominance of lymphoid malignancies in those with both diseases (92 %) and in the HMs among family members of RCC patients (79 %). The majority (95 %) of HM relatives were first or second degree relatives of the patient with RCC. Thirty of 34 parent/child pairs demonstrated age of onset anticipation in which the child developed either disease at a younger age than the parent. The co-occurrence of RCC and HM in the same patient has been shown to be significantly greater than expected. Families also appear to have an increased association. The appearance of anticipation suggests that genetic factors may be significant in this association of RCC and HM.

Entities:  

Keywords:  Familial hematologic malignancies; Lymphoma; Renal cell cancer

Mesh:

Year:  2016        PMID: 27334456     DOI: 10.1007/s10689-016-9911-7

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  92 in total

1.  Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin's lymphomas of individual patients diagnosed with both malignancies.

Authors:  Polly R Etkind; Alexandre F R Stewart; Thambi Dorai; Daniel J Purcell; Peter H Wiernik
Journal:  Clin Cancer Res       Date:  2004-09-01       Impact factor: 12.531

2.  Comprehensive analysis of PTEN status in Sezary syndrome.

Authors:  Cristina Cristofoletti; Maria Cristina Picchio; Cristina Lazzeri; Valeria Tocco; Elena Pagani; Antonella Bresin; Barbara Mancini; Francesca Passarelli; Antonio Facchiano; Enrico Scala; Giuseppe Alfonso Lombardo; Maria Cantonetti; Elisabetta Caprini; Giandomenico Russo; Maria Grazia Narducci
Journal:  Blood       Date:  2013-09-23       Impact factor: 22.113

3.  Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis.

Authors:  Ru Jiang; Oleksandr Ekshyyan; Tara Moore-Medlin; Xiaohua Rong; Sean Nathan; Xin Gu; Fleurette Abreo; Eben L Rosenthal; Mingxia Shi; Joseph T Guidry; Rona S Scott; Lindsey M Hutt-Fletcher; Cherie-Ann O Nathan
Journal:  J Oral Pathol Med       Date:  2014-07-18       Impact factor: 4.253

4.  Families with both Hodgkin lymphoma and multiple myeloma in their pedigrees.

Authors:  Peter H Wiernik; Dona Wickramasinghe; Janice P Dutcher
Journal:  Clin Adv Hematol Oncol       Date:  2015-04

5.  Renal cell carcinoma with intravascular lymphomatosis: a case report of unusual collision tumors with review of the literature.

Authors:  B Y Wang; J A Strauchen; D Rabinowitz; S M Tillem; P D Unger
Journal:  Arch Pathol Lab Med       Date:  2001-09       Impact factor: 5.534

Review 6.  [Non-Hodgkin's lymphoma, renal carcinoma, and meningioma. A clinical case].

Authors:  E Lolli; R Matteoni; A Barbieri; M D'Ambrosi; F Archontakis
Journal:  Ann Ital Chir       Date:  1998 Jan-Feb       Impact factor: 0.766

7.  High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma.

Authors:  Saloua Toujani; Philippe Dessen; Nathalie Ithzar; Gisèle Danglot; Catherine Richon; Yegor Vassetzky; Thomas Robert; Vladimir Lazar; Jacques Bosq; Lydie Da Costa; Christine Pérot; Vincent Ribrag; Catherine Patte; Jöelle Wiels; Alain Bernheim
Journal:  PLoS One       Date:  2009-09-17       Impact factor: 3.240

8.  Detection of human mammary tumor virus proteins in human breast cancer cells.

Authors:  Stella M Melana; Irene Nepomnaschy; Jennifer Hasa; Alina Djougarian; Anna Djougarian; James F Holland; Beatriz G T Pogo
Journal:  J Virol Methods       Date:  2009-09-23       Impact factor: 2.014

9.  Molecular genetics of clear-cell renal cell carcinoma.

Authors:  James Brugarolas
Journal:  J Clin Oncol       Date:  2014-05-12       Impact factor: 44.544

10.  Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.

Authors:  A Kinch; L Cavelier; M Bengtsson; E Baecklund; G Enblad; C Backlin; U Thunberg; C Sundström; K Pauksens
Journal:  Am J Transplant       Date:  2014-10-10       Impact factor: 8.086

View more
  2 in total

1.  Case Report: New Onset Lymphadenopathy After Immune Checkpoint Inhibitor Therapy Presents a Clinicopathological and Radiological Challenge.

Authors:  Matthew Scarlotta; Robin Avery; Ezra Baraban; Zahra Maleki; Yasser Ged
Journal:  Front Oncol       Date:  2022-05-20       Impact factor: 5.738

Review 2.  Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases.

Authors:  Youxi Yu; Xiaoju Shi; Xingtong Wang; Ping Zhang; Ou Bai; Yan Li
Journal:  Cell Biosci       Date:  2022-03-12       Impact factor: 7.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.